Application Nr Approved Date Route Status External Links
ANDA210188 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ranolazine Extended-Release Tablet Is Indicated For The Treatment Of Chronic Angina. Ranolazine Extended-Release Tablet May Be Used With Beta-Blockers, Nitrates, Calcium Channel Blockers, Anti-Platelet Therapy, Lipid-Lowering Therapy, Ace Inhibitors, And Angiotensin Receptor Blockers. Ranolazine Extended-Release Tablet Is An Antianginal Indicated For The Treatment Of Chronic Angina. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ranolazine RANOLAZINE ZINC95619101

Comments